Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Hospira | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Hospira

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Hospira

2Q Revenues: $671 million (+1%)

2Q Earnings: $54 million (-25%)

YTD Revenues: $1.3 billion (+1%)

YTD Earnings: $134 million (-10%)

Comments: R&D expense rose 19% percent in the quarter to $39 million. S,G&A expense in the quarter was $111 million, or 17% of sales, compared with $87 million, or 13% of sales in 2Q2005. The company completed its legal separation from Abbott in the quarter, including the transition of the remaining countries to Hospira.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters